BCL11A gene DNA methylation contributes to the risk of type 2 diabetes in males
- PMID: 25009601
- PMCID: PMC4079426
- DOI: 10.3892/etm.2014.1783
BCL11A gene DNA methylation contributes to the risk of type 2 diabetes in males
Abstract
BCL11A is a critical modulator involved in hemoglobin switching. Recent studies have established an association between BCL11A gene polymorphisms and a risk of type 2 diabetes (T2D). The aim of the present study was to assess the correlation between BCL11A DNA methylation and T2D. A total of 48 T2D cases and 48 age- and gender-matched controls were recruited to evaluate BCL11A methylation using bisulfite pyrosequencing technology. Although no significant association was observed in BCL11A methylation between T2D patients and healthy controls (P=0.322), breakdown analysis by gender identified a significant association between BCL11A methylation and T2D in males (P=0.018). Notably, there was also a significant female-specific association between the mean BCL11A DNA methylation and triglyceride (TG) concentration (r=-0.34; P=0.019). The results indicated that BCL11A methylation contributed to the risk of T2D in males. In addition, BCL11A methylation may have an effect on the development of T2D by influencing TG metabolism. Thus, gender difference may provide new information to aid the understanding of T2D pathogenesis.
Keywords: BCL11A; CpG island; DNA methylation; gender; type 2 diabetes.
Figures
Similar articles
-
Elevated CpG island methylation of GCK gene predicts the risk of type 2 diabetes in Chinese males.Gene. 2014 Sep 1;547(2):329-33. doi: 10.1016/j.gene.2014.06.062. Epub 2014 Jun 30. Gene. 2014. PMID: 24992032
-
Gender-dependent miR-375 promoter methylation and the risk of type 2 diabetes.Exp Ther Med. 2013 Jun;5(6):1687-1692. doi: 10.3892/etm.2013.1069. Epub 2013 Apr 18. Exp Ther Med. 2013. PMID: 23837055 Free PMC article.
-
No association between IRS‑1 promoter methylation and type 2 diabetes.Mol Med Rep. 2013 Sep;8(3):949-53. doi: 10.3892/mmr.2013.1569. Epub 2013 Jul 3. Mol Med Rep. 2013. PMID: 23828647
-
Epigenetic regulation of insulin action and secretion - role in the pathogenesis of type 2 diabetes.J Intern Med. 2020 Aug;288(2):158-167. doi: 10.1111/joim.13049. Epub 2020 May 3. J Intern Med. 2020. PMID: 32363639 Review.
-
The potential use of DNA methylation biomarkers to identify risk and progression of type 2 diabetes.Front Endocrinol (Lausanne). 2015 Mar 30;6:43. doi: 10.3389/fendo.2015.00043. eCollection 2015. Front Endocrinol (Lausanne). 2015. PMID: 25870586 Free PMC article. Review.
Cited by
-
Molecular analysis of the erythroid phenotype of a patient with BCL11A haploinsufficiency.Blood Adv. 2021 May 11;5(9):2339-2349. doi: 10.1182/bloodadvances.2020003753. Blood Adv. 2021. PMID: 33938942 Free PMC article.
-
The role of DNA methylation in the pathogenesis of type 2 diabetes mellitus.Clin Epigenetics. 2020 Jul 11;12(1):104. doi: 10.1186/s13148-020-00896-4. Clin Epigenetics. 2020. PMID: 32653024 Free PMC article. Review.
-
Detecting genome-wide directional effects of transcription factor binding on polygenic disease risk.Nat Genet. 2018 Oct;50(10):1483-1493. doi: 10.1038/s41588-018-0196-7. Epub 2018 Sep 3. Nat Genet. 2018. PMID: 30177862 Free PMC article.
-
NDRG4 hypermethylation is a potential biomarker for diagnosis and prognosis of gastric cancer in Chinese population.Oncotarget. 2017 Jan 31;8(5):8105-8119. doi: 10.18632/oncotarget.14099. Oncotarget. 2017. PMID: 28042954 Free PMC article.
-
Blood-Based DNA Methylation Biomarkers for Type 2 Diabetes: Potential for Clinical Applications.Front Endocrinol (Lausanne). 2018 Dec 4;9:744. doi: 10.3389/fendo.2018.00744. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 30564199 Free PMC article. Review.
References
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous